Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Michael Joseph Gutierrez, MD
Internal Medicine · AUSTIN, TX · NPI 1174810048
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 398 | 73 |
| Gabapentin | Gabapentin | 326 | 50 |
| Amlodipine Besylate | Amlodipine Besylate | 244 | 46 |
| Eliquis | Apixaban | 214 | 28 |
| Divalproex Sodium | Divalproex Sodium | 199 | 27 |
| Levothyroxine Sodium | Levothyroxine Sodium | 186 | 33 |
| Potassium Chloride | Potassium Chloride | 180 | 34 |
| Sertraline Hcl | Sertraline Hcl | 178 | 30 |
| Tamsulosin Hcl | Tamsulosin Hcl | 178 | 33 |
| Furosemide | Furosemide | 169 | 51 |
| Donepezil Hcl | Donepezil Hcl | 143 | 21 |
| Carvedilol | Carvedilol | 131 | 27 |
| Pantoprazole Sodium | Pantoprazole Sodium | 131 | 34 |
| Lisinopril | Lisinopril | 128 | 29 |
| Metoprolol Tartrate | Metoprolol Tartrate | 128 | 33 |
| Myrbetriq | Mirabegron | 117 | 13 |
| Lorazepam | Lorazepam | 111 | 33 |
| Trazodone Hcl | Trazodone Hcl | 104 | 28 |
| Levetiracetam | Levetiracetam | 98 | 20 |
| Baclofen | Baclofen | 96 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 95 | 19 |
| Tramadol Hcl | Tramadol Hcl | 94 | 26 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 89 | 28 |
| Metformin Hcl | Metformin Hcl | 85 | 15 |
| Losartan Potassium | Losartan Potassium | 81 | 21 |
| Fluticasone Propionate | Fluticasone Propionate | 72 | 17 |
| Memantine Hcl | Memantine Hcl | 72 | 13 |
| Mirtazapine | Mirtazapine | 67 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 65 | 22 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 65 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 64 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 54 | 14 |
| Hydralazine Hcl | Hydralazine Hcl | 54 | 16 |
| Metoprolol Succinate | Metoprolol Succinate | 54 | 19 |
| Pregabalin | Pregabalin | 53 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 52 | suppressed |
| Allopurinol | Allopurinol | 51 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 49 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 48 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 46 | suppressed |
| Latanoprost | Latanoprost | 45 | 13 |
| Simvastatin | Simvastatin | 45 | suppressed |
| Olanzapine | Olanzapine | 44 | suppressed |
| Risperidone | Risperidone | 44 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 43 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 43 | 14 |
| Divalproex Sodium Er | Divalproex Sodium | 41 | suppressed |
| Nystatin | Nystatin | 41 | 20 |
| Buspirone Hcl | Buspirone Hcl | 40 | suppressed |
| Torsemide | Torsemide | 40 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 38 | 32 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 38 | suppressed |
| Methocarbamol | Methocarbamol | 37 | 14 |
| Brimonidine Tartrate | Brimonidine Tartrate | 33 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 32 | 13 |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 32 | suppressed |
| Atenolol | Atenolol | 31 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 31 | 13 |
| Sucralfate | Sucralfate | 31 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 30 | 11 |
| Glipizide | Glipizide | 30 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 29 | suppressed |
| Finasteride | Finasteride | 29 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 29 | suppressed |
| Clonazepam | Clonazepam | 28 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 28 | 18 |
| Xarelto | Rivaroxaban | 28 | suppressed |
| Alprazolam | Alprazolam | 26 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 26 | 26 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 26 | suppressed |
| Savella | Milnacipran Hcl | 26 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 25 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 25 | 18 |
| Ezetimibe | Ezetimibe | 25 | suppressed |
| Lactulose | Lactulose | 25 | suppressed |
| Gemtesa | Vibegron | 24 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 24 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 24 | suppressed |
| Temazepam | Temazepam | 24 | suppressed |
| Trulicity | Dulaglutide | 24 | suppressed |
| Januvia | Sitagliptin Phosphate | 23 | suppressed |
| Timolol Maleate | Timolol Maleate | 22 | suppressed |
| Cyclosporine | Cyclosporine | 21 | suppressed |
| Jardiance | Empagliflozin | 21 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 21 | suppressed |
| Spironolactone | Spironolactone | 21 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 20 | suppressed |
| Cephalexin | Cephalexin | 20 | 17 |
| Midodrine Hcl | Midodrine Hcl | 20 | suppressed |
| Mirabegron Er | Mirabegron | 20 | suppressed |
| Nifedipine Er | Nifedipine | 20 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 20 | suppressed |
| Valsartan | Valsartan | 20 | suppressed |
| Topiramate | Topiramate | 19 | suppressed |
| Abilify Maintena | Aripiprazole | 18 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 18 | suppressed |
| Diazepam | Diazepam | 18 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 18 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 18 | 17 |
| Lamotrigine | Lamotrigine | 18 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 18 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 18 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 17 | 15 |
| Ceftriaxone | Ceftriaxone Sodium | 17 | 12 |
| Lacosamide | Lacosamide | 17 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 17 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 17 | suppressed |
| Zonisamide | Zonisamide | 17 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 16 | 14 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 16 | suppressed |
| Rivastigmine | Rivastigmine | 16 | suppressed |
| Sevelamer Hcl | Sevelamer Hcl | 16 | suppressed |
| Amoxicillin | Amoxicillin | 15 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 15 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 15 | suppressed |
| Famotidine | Famotidine | 15 | suppressed |
| Primidone | Primidone | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | 12 |
| Vascepa | Icosapent Ethyl | 15 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 14 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 14 | 13 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 14 | suppressed |
| Omeprazole | Omeprazole | 14 | suppressed |
| Zaleplon | Zaleplon | 14 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 14 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 13 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Methadone Hcl | Methadone Hcl | 12 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 11 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 11 | suppressed |
| Bupropion Xl | Bupropion Hcl | 11 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Guanfacine Hcl Er | Guanfacine Hcl | 11 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 11 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 11 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 11 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error